the National Natural Science Foundation of China(Nos.22307009,82374155,82073997,82104376);the Sichuan Science and Technology Program(Nos.2023NSFSC1108,2024NSFTD0023);the Postdoctoral Research Project of Sichuan Province;the Xinglin Scholar Research Promotion Project of Chengdu University of TCM.
Background:Triple-negative breast cancer(TNBC),characterized by its lack of traditional hormone receptors and HER2,presents a significant challenge in oncology due to its poor response to conventional therapies.Autoph...
supported by National Natural Science Foundation of China (30300449);the Traditional Chinese Medicine Foundation of State Administration (02-03ZP52 );the Fund from Chongqing Medical University (XBYB2007104,XBYB2007108)